The following represents disclosure information provided by authors of this abstract. The ASCO Scientific Program Committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered self-held and compensated unless otherwise noted. Employment/Leadership relationships are considered compensated employment unless otherwise noted. L = Leadership, U = Uncompensated, I = Immediate Family Member, B = Both Myself and Immediate Family Member, Inst = My Institution
An epithelial-mesenchymal transition (EMT) gene signature to predict resistance to EGFR inhibition and AXL identification as a therapeutic target in head and neck squamous cell carcinoma.
Robert Cardnell
No relevant relationships to disclose
Lixia Diao
No relevant relationships to disclose
Jing Wang
No relevant relationships to disclose
David Bearss
No relevant relationships to disclose
Steven Warner
No relevant relationships to disclose
You Hong Fan
No relevant relationships to disclose
Uma Giri
No relevant relationships to disclose
Michael D. Story
No relevant relationships to disclose
John N. Weinstein
No relevant relationships to disclose
Kevin R. Coombes
No relevant relationships to disclose
Michelle D. Williams
No relevant relationships to disclose
The Cancer Genome Atlas Reseach Network
No relevant relationships to disclose
Ignacio Ivan Wistuba
No relevant relationships to disclose
Gordon B. Mills
No relevant relationships to disclose
Jeffrey Myers
No relevant relationships to disclose
William Nassib William
Research Funding - Astellas Pharma; Lilly
K. Kian Ang
No relevant relationships to disclose
John Heymach
No relevant relationships to disclose
Lauren Averett Byers
No relevant relationships to disclose